Systemic Juvenile Idiopathic Arthritis (sJIA)
5 clinical trials · Condition
◉ Watch Systemic Juvenile Idiopathic Arthritis (sJIA)
| Record | Firm | Date |
|---|---|---|
| ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab (NCT02296424) | Novartis Pharmaceuticals | 2014-11-17 |
| Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT (NCT01962415) | Paul Szabolcs | 2014-02-04 |
Track Systemic Juvenile Idiopathic Arthritis (sJIA) automatically
Every clearance here is in the API, with alerts when new ones post.